New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 1, 2013
07:56 EDTCTRXCatamaran pullback a buying opportunity, says Leerink
Leerink says it heard nothing on Catamaran's earnings call that would indicate management is reducing guidance or cautious on 2014 EBITDA expectations. The firm notes shares sold off 11% intraday. Leerink said it would be a buyer of Catamaran and keeps an Outperform rating on the name with a $68 price target.
News For CTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
07:13 EDTCTRXUBM Tech to hold a conference
Subscribe for More Information
April 23, 2015
12:08 EDTCTRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 22, 2015
10:02 EDTCTRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTCTRXCatamaran downgraded to Hold from Buy at Maxim
Maxim downgraded Catamaran to Hold citing the takeover by OptumRx as it does not believe another suitor will emerge with a counter bid.
April 16, 2015
06:05 EDTCTRXUnitedHealth says Catamaran combination to contribute 30c to 2016 earnings
April 15, 2015
11:51 EDTCTRXExpress Scripts down 2% as Walgreens speaks at analyst day
Subscribe for More Information
April 13, 2015
10:33 EDTCTRXOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use